Document is current

Article History

Received: 2 September 2024

Accepted: 11 March 2025

First Online: 3 April 2025

Declarations

:

: E. Valeriani, G. Astorri, A. Pannunzio, D. Pastori, I.M. Palumbo, D. Menichelli, D. Santagata, L. D’Innocenzo, A. Tufano, K. Satula, R. Marcucci, A. Chistolini, F. Dragoni, T. Bucci, and P. Pignatelli have nothing to disclose. M.P. Donadini received grants or contracts from Italian Ministry of Health outside the submitted work and participation on a Data Safety Monitoring Board or Advisory Board from PlasFree outside the submitted work. E. De Candia received consulting fees and Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Viatris–Mylan and Daiichi Sanchyo outside the submitted work. M. Berteotti received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Novartis, Amgen, and Daiichi Sankyo outside the submitted work. W. Ageno received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Pfizer, Astra Zeneca, Viatris, and Sanofi outside the submitted work and participation on a Data Safety Monitoring Board or Advisory Board from Astra Zeneca, Bayer, BMS-Pfizer, Norgine, Sanofi, Viatris outside the submitted work. C. Becattini received consulting fees and Payment or honoraria for lectures presentations, speakers bureaus, manuscript writing, or educational events from Bayer Healthcare, Bristol-Myers Squibb, and Daiichi Sankyo outside the submitted work.

: This study was performed in accordance with the principles of Helsinki Declaration.

: All included patients consented the use of their data for study purposes.